���发背景与监管地位 — Field Notes

By Editorial Desk · published 2025-10-22 · last reviewed 2025-11-05 · Faq

If you have been reading about 合成七肽 and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.

Updated 2025-11-05. Numbers and descriptions here follow the published literature rather than marketing material.

研发背景与监管地位

Semax 是人工设计的七肽，序列为 Met-Glu-His-Phe-Pro-Gly-Pro，骨架取自促肾上腺皮质激素片段 ACTH(4-10)。它于二十世纪八十年代在苏联的分子遗传学研究机构内合成。设计目标是保留该片段与注意力和记忆相关的活性，同时剔除促皮质激素释放等内分泌作用。此后俄罗斯将其登记为药品并进入临床使用。

当时的短肽研究普遍关注能否穿越血脑屏障、在低剂量下产生中枢效应，Semax 属于这一路线。鼻内给药是其主要使用方式，俄语文献报道的适应症涵盖缺血性卒中、短暂性脑缺血发作、认知功能减退以及视神经病变。这些研究大多发表在当地期刊上，样本规模与终点设置同西方试验惯例存在差异，国际同行对其临床证据的强度看法不一。

Semax Origin and Molecular Structure

Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It is described in the literature as an analogue of the ACTH(4–10) fragment, a short N-terminal portion of adrenocorticotropic hormone that retains some neurotropic activity without the full hormonal effects of the parent peptide. The molecule carries a methionine residue at the N-terminus and two proline residues near the C-terminus, features that shape both its interactions with receptor systems and its chemical stability. The free peptide corresponds to the formula C37H51N9O10S and a molecular mass near 813.9 Da.

The compound was developed in the 1980s at the Institute of Molecular Genetics in Moscow, where it emerged from research on short ACTH fragments and their effects on the central nervous system. Russian pharmaceutical listings describe it as a nootropic and neuroprotective agent, most often formulated as nasal drops. It is not a marketed medicine in the United States or the European Union, and no pharmacopoeial monograph covers it. Consequently, most published clinical experience with the substance originates from a small number of research centres, mainly in Russia and neighbouring countries.

Semax at a glance

Supporting material

== Genomics == Hydra has more than 20,000 genes, along with a set of six actinoporin-like toxin genes found in its nematocysts. An ortholog comparison analysis done in 2013 demonstrated that Hydra share a minimum of 6,071 genes with humans. Hydra is becoming an increasingly better model system as more genetic approaches become available. Transgenic hydra have become attractive model organisms to study the evolution of immunity. A draft of the genome of Hydra magnipapillata was reported in 2010. The genus Hydra is divided into two clades, the green hydras (e.g. H. viridissima) and the brown hydras (e.g. H. oligactis, H. vulgaris). The genomes of cnidarians are usually less than 500 Mb (megabases) in size, as in the green hydras, which has a genome size of approximately 300 Mb. In contrast, the genomes of brown hydras are approximately 1 Gb in size. This is because the brown hydra genome is the result of an expansion event involving LINEs, a type of transposable elements, in particular, a single family of the CR1 class. This expansion is unique to this subgroup of the genus Hydra and is absent in the green hydra, which has a repeating landscape similar to other cnidarians. These genome characteristics make Hydra attractive for studies of transposon-driven speciations and genome expansions. Due to the simplicity of their life cycle when compared to other hydrozoans, Hydras have lost many genes that correspond to cell types or metabolic pathways of which the ancestral function is still unknown.

== Function == HIV-1 PR serves a dual purpose. Precursor HIV-1 PR is responsible for catalyzing its own production into mature PR enzymes via PR auto-processing. Mature protease is able to hydrolyze peptide bonds on the Gag-Pol polyproteins at nine specific sites, processing the resulting subunits into mature, fully functional proteins. These cleaved proteins, including reverse transcriptase, integrase, and RNaseH, are encoded by the coding region components necessary for viral replication.

In 1998, he voted for a bill that would have increased minimum sentencing for possessing a gun while committing a federal crime to ten years in prison, including nonviolent crimes such as marijuana possession. In 2005, Sanders voted for the Protection of Lawful Commerce in Arms Act. The purpose of the act was to prevent firearms manufacturers and dealers from being held liable for negligence when crimes have been committed with their products. As of 2016, he said that he has since changed his position and would vote for legislation to defeat this bill.

Sources: en.wikipedia.org

Related pages on this site

• Scheduled reference
• Seasonal notes
• Focused analysis
• Automated comparison
• Verified toolkit
• Scheduled casebook
• Portable guide
• Seasonal toolkit

Notes from published material

== Role in disease == Activation of prothrombin is crucial in physiological and pathological coagulation. Various rare diseases involving prothrombin have been described (e.g., hypoprothrombinemia). Anti-prothrombin antibodies in autoimmune disease may be a factor in the formation of the lupus anticoagulant (also known as antiphospholipid syndrome). Hyperprothrombinemia can be caused by the G20210A mutation. Thrombin, a potent vasoconstrictor and mitogen, is implicated as a major factor in vasospasm following subarachnoid hemorrhage. Blood from a ruptured cerebral aneurysm clots around a cerebral artery, releasing thrombin. This can induce an acute and prolonged narrowing of the blood vessel, potentially resulting in cerebral ischemia and infarction (stroke). Beyond its key role in the dynamic process of thrombus formation, thrombin has a pronounced pro-inflammatory character, which may influence the onset and progression of atherosclerosis. Acting via its specific cell membrane receptors (protease activated receptors: PAR-1, PAR-3 and PAR-4), which are abundantly expressed in all arterial vessel wall constituents, thrombin has the potential to exert pro-atherogenic actions such as inflammation, leukocyte recruitment into the atherosclerotic plaque, enhanced oxidative stress, migration and proliferation of vascular smooth muscle cells, apoptosis and angiogenesis. Thrombin is implicated in the physiology of blood clots. Its presence indicates the existence of a clot. In 2013 a system for detecting the presence of thrombin was developed in mice.

Coercive strategies experienced in the delivery room and at work, were also entrenched in the process of clinical trials for birth control pills in 1955. These trials took place in poor areas in Puerto Rico like San Juan. Outside of San Juan, the Common Wealth Health Department controlled more than 19 free clinics. These clinics were reported to be operating at full capacity as approximately 1,000 sterilizations were completed a month. Within these clinics, low socioeconomic women were unknowingly being used as test subjects. Class inequality was apparent during these trials due to educated middle-class women fearing the side effects and refusing to try the new medication while poor-less educated women unknowingly became test subjects out of desperation to avoid pregnancy and ultimately sterilization. On many occurrences, these pills such as Enovid, contained an unusually high quantity of hormones compared to 21st century birth control pills. Doctors disregarded women that reported nausea, blood clotting, and depression. Three women allegedly died during the underground testing of this pill, but their deaths were never put to trial or investigated. In the mainland, testing for this pill, Enovid, continued and was approved in 1957 regardless of dangerous and adverse side effects. Additionally, poor Puerto Rican women in Ryder Memorial Hospital were tested on for six different variations of birth control along with the IUD in the 1960s.

=== Metabolism === Ibutilide has a high systemic plasma clearance that closes to the hepatic blood flow (29mL/min/kg). Its metabolic pathway is via liver's cytochrome P450 system by isoenzymes other than CYP3A4 and CYP2D6 by which the heptyl side chain of ibutilide is oxidized. With eight metabolites are detected in the urine, however, only one is an active metabolite that shares the similar electrophysiologic property of the Class III antiarrhythmic agents. The plasma concentration of this metabolite is only less than 10% of ibutilide.

Sources: en.wikipedia.org

Frequently asked questions